Femasys (FEMY) Capital Expenditures (2020 - 2026)
Femasys (FEMY) reported Capital Expenditures of $79138.0 for Q1 2026, down 18.08% on a YoY basis from $96605.0 in Q1 2025, and down 43.41% quarter-over-quarter from $139840.0 in Q4 2025.
Femasys (FEMY) Capital Expenditures (2020 - 2026) Analysis & Trends
Femasys has reported Capital Expenditures for 7 years, with the latest figure at $79138.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures fell 18.08% year-over-year to $79138.0; the trailing twelve-month figure through Mar 2026 stood at $507540.0 (down 36.06% YoY), and the FY2025 full-year result was $525007.0, down 31.07% from the prior year.
- Capital Expenditures for Q1 2026 stood at $79138.0, down from $139840.0 in the prior quarter.
- The five-year high for Capital Expenditures was $407936.0 in Q3 2024, with the low at $8901.0 in Q1 2023.
- Historically, Capital Expenditures has averaged $112779.0 across 5 years, with a median of $94229.0 in 2025.
- Annual changes were most pronounced in 2023 — Capital Expenditures tumbled 92.61% — and 2024, when it jumped 1401.48%.
- Femasys' Capital Expenditures stood at $93877.0 in 2022, then tumbled by 52.17% to $44899.0 in 2023, then surged by 137.85% to $106792.0 in 2024, then surged by 30.95% to $139840.0 in 2025, then plunged by 43.41% to $79138.0 in 2026.
- The last three Capital Expenditures figures came in at $79138.0 (Q1 2026), $139840.0 (Q4 2025), and $194333.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 103.30 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 125.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 33.65 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 26.10 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 84.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 86.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 30.79 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 137.00 Mn |
| 10 | Femasys | 254.59 Mn | 249.20 Mn | - | 79,138.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79,138.00 |
| Mar 31, 2026 | 79,138.00 |
| Dec 31, 2025 | 139,840.00 |
| Dec 31, 2025 | 139,840.00 |
| Sep 30, 2025 | 194,333.00 |
| Sep 30, 2025 | 194,333.00 |
| Jun 30, 2025 | 94,229.00 |
| Jun 30, 2025 | 94,229.00 |
| Mar 31, 2025 | 96,605.00 |
| Mar 31, 2025 | 96,605.00 |
| Dec 31, 2024 | 106,792.00 |
| Dec 31, 2024 | 106,792.00 |
| Sep 30, 2024 | 407,936.00 |
| Sep 30, 2024 | 407,936.00 |
| Jun 30, 2024 | 182,421.00 |
| Jun 30, 2024 | 182,421.00 |
| Mar 31, 2024 | 64,557.00 |
| Mar 31, 2024 | 64,557.00 |
| Dec 31, 2023 | 44,899.00 |
| Dec 31, 2023 | 44,899.00 |